KMT2A and acute myeloid leukemia: The effects of this mutation included a severe downregulation of nuclear Rela, a canonical NFκB subunit, which is elevated in and essential for MLL-AF9 AML (137), as well as upregulation of nuclear non-canonical NFκB subunits Relb, p50, and p52 (136).